Ingredient or product comparison
Best GHK-Cu Dosage Skin Tightening 2026: Protocol Comparison
Subcutaneous Injection 1–3mg daily Once daily 85–90% 6–8 weeks for measurable collagen density increase Highest precision and bioavailability; requires sterile technique and proper storage; ideal for controlled research protocols Topical (Standard Cream) 0.5–2
This source-based comparison does not add ratings or recommend a winner.
- Subcutaneous Injection
- 1–3mg daily
- Once daily
- 85–90%
- 6–8 weeks for measurable collagen density increase
- Highest precision and bioavailability; requires sterile technique and proper storage; ideal for controlled research protocols
- Topical (Standard Cream)
- 0.5–2% concentration
- Twice daily
- 2–5% without enhancement
- 8–12 weeks for visible skin texture improvement
- Lowest barrier to use; heavily dependent on formulation quality; less predictable tissue-level dosing
- Topical (Liposomal/Nano)
- 0.5–1.5% concentration
- 15–30%
- 6–10 weeks for elasticity improvement
- Improved penetration over standard creams; still requires consistent application; formulation stability is critical
- Microneedling + Topical
- 0.5–1% concentration
- Post-needling application
- 30–50% (transient)
- 4–6 weeks for collagen remodeling markers
- Combines mechanical stimulation with peptide delivery; controlled injury component makes isolating GHK-Cu effect difficult
- Oral (Experimental)
- 50–100mg daily
- <1% (first-pass metabolism)
- Insufficient data
- Not recommended; extremely poor bioavailability due to gastric degradation and hepatic first-pass effect
- The highest-value protocol for skin tightening research in 2026 combines 2mg subcutaneous GHK-Cu daily for 8–12 weeks with concurrent 1% topical liposomal formulation applied to target areas twice daily. This dual-route approach delivers systemic collagen synthesis support while maximizing local dermal concentration at specific sites.